Cargando…

Mouse Models of Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss and personality changes, eventually leading to dementia. The pathological hallmarks of AD are senile plaques and neurofibrillary tangles, which comprise abnormally aggregated β-amyloid peptide (Aβ) and hyperphospho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254908/ https://www.ncbi.nlm.nih.gov/pubmed/35799899 http://dx.doi.org/10.3389/fnmol.2022.912995

Ejemplares similares

ADAMTS4 is involved in the production of the Alzheimer disease amyloid biomarker APP669-711
por: Matsuzaki, Masaya, et al.
Publicado: (2023)

The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease
por: Tian, Yanna, et al.
Publicado: (2023)

Deletion of p75(NTR) rescues the synaptic but not the inflammatory status in the brain of a mouse model for Alzheimer’s disease
por: Demuth, Hendrik, et al.
Publicado: (2023)

Fiberoptic hemodynamic spectroscopy reveals abnormal cerebrovascular reactivity in a freely moving mouse model of Alzheimer’s disease
por: Gareau, Daniel S., et al.
Publicado: (2023)

The cellular model for Alzheimer's disease research: PC12 cells
por: Xie, Danni, et al.
Publicado: (2023)

Identification ferroptosis-related hub genes and diagnostic model in Alzheimer’s disease
por: Zhao, Huabin, et al.
Publicado: (2023)

Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
por: Flannagan, Kaitlin, et al.
Publicado: (2023)

The Impact of ESCRT on Aβ(1-42) Induced Membrane Lesions in a Yeast Model for Alzheimer’s Disease
por: Fruhmann, Gernot, et al.
Publicado: (2018)

HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease
por: Braz, Sandra O., et al.
Publicado: (2023)

Nucleosome assembly protein 1-like 5 alleviates Alzheimer’s disease-like pathological characteristics in a cell model
por: Wang, Bingyan, et al.
Publicado: (2022)

Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease
por: Lan, Zhen, et al.
Publicado: (2022)

Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease
por: Wang, Niya, et al.
Publicado: (2023)

Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod
por: Jęśko, Henryk, et al.
Publicado: (2021)

Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease
por: Ramos, Adriana, et al.
Publicado: (2022)

Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
por: Nordvall, Gunnar, et al.
Publicado: (2023)

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
por: Ly, Philip T.T., et al.
Publicado: (2011)

Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer’s disease
por: Xu, Lin-Lin, et al.
Publicado: (2017)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Peripheral metabolic alterations associated with pathological manifestations of Parkinson’s disease in gut-brain axis-based mouse model
por: Huh, Eugene, et al.
Publicado: (2023)

Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
por: Rudajev, Vladimir, et al.
Publicado: (2022)

Editorial: Apoptosis, autophagy, and mitophagy dysfunction in Alzheimer's disease: Evolving emergence and mechanisms
por: Kalra, Rajkumar Singh, et al.
Publicado: (2022)

RNA Quality in Post-mortem Human Brain Tissue Is Affected by Alzheimer’s Disease
por: Highet, Blake, et al.
Publicado: (2021)

Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer’s Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2021)

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer’s disease
por: Fan, Li-Yuan, et al.
Publicado: (2023)

Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
por: Sbai, Oualid, et al.
Publicado: (2023)

Identification of mitochondrial-related genes as potential biomarkers for the subtyping and prediction of Alzheimer’s disease
por: Ma, Wenhao, et al.
Publicado: (2023)

Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model
por: Benderradji, Hamza, et al.
Publicado: (2022)

Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2022)

Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer’s Disease
por: Consens, Micaela E., et al.
Publicado: (2022)

Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
por: Mamsa, Somayra S. A., et al.
Publicado: (2021)

GAP-43 closely interacts with BDNF in hippocampal neurons and is associated with Alzheimer's disease progression
por: Lee, Ye Ji, et al.
Publicado: (2023)

Analyzing alternative splicing in Alzheimer’s disease postmortem brain: a cell-level perspective
por: Farhadieh, Mohammad-Erfan, et al.
Publicado: (2023)

Innate immune activation and aberrant function in the R6/2 mouse model and Huntington’s disease iPSC-derived microglia
por: Gasser, Julien, et al.
Publicado: (2023)

Pepperberg plot: Modeling flash response saturation in retinal rods of mouse
por: Caruso, Giovanni, et al.
Publicado: (2023)

Mouse all-cone retina models of Cav1.4 synaptopathy
por: Laird, Joseph G., et al.
Publicado: (2023)

Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer’s and Parkinson’s disease
por: Gok, Muslum, et al.
Publicado: (2022)

Alzheimer’s disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs
por: Arizaca Maquera, Karol Andrea, et al.
Publicado: (2023)

Changes in voiding behavior in a mouse model of Alzheimer’s disease
por: Biallosterski, B. T., et al.
Publicado: (2015)

Dissecting Alzheimer disease in Down syndrome using mouse models
por: Choong, Xun Yu, et al.
Publicado: (2015)

Transcriptome Analysis of Pineal Glands in the Mouse Model of Alzheimer’s Disease
por: Nam, Kwang Il, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t5805v0ss2vtpgvr741tk9d53p